Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Elanco Animal Health

    NYSE: ELAN · Real-Time Price · USD
    13.46
    -0.06 (-0.44%)
    At close: May 30, 2025, 3:59 PM
    13.44
    -0.15%
    After-hours: May 30, 2025, 05:21 PM EDT
    -0.44%
    Bid 13.25
    Market Cap 6.68B
    Revenue (ttm) 4.43B
    Net Income (ttm) 373M
    EPS (ttm) 0.75
    PE Ratio (ttm) 17.95
    Forward PE 14.25
    Analyst Hold
    Ask 13.45
    Volume 4,670,779
    Avg. Volume (20D) 5,738,024
    Open 13.46
    Previous Close 13.52
    Day's Range 13.24 - 13.66
    52-Week Range 8.02 - 18.80
    Beta 1.50

    About ELAN

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ELAN
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ELAN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 weeks ago
    +26.29%
    Elanco Animal Health shares arre trading higher af... Unlock content with Pro Subscription
    6 months ago
    +12.75%
    Elanco Animal Health shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results and issued Q4 adjusted EPS guidance above estimates.
    news image

    2 weeks ago · seekingalpha.com

    Elanco: Deleveraging Takes Time

    Elanco's shares have been pressured due to pipeline delays and debt from the Bayer acquisition, causing cautious optimism despite recent valuation resets. The company focuses on animal health, with ba...

    news image

    3 weeks ago · https://thefly.com

    Elanco price target raised to $11 from $9.50 at Leerink

    Leerink analyst Daniel Clark raised the firm's price target on Elanco to $11 from $9.50 and keeps a Market Perform rating on the shares. The firm says the company's quarter was solid, and its exposure...

    news image

    3 weeks ago · seekingalpha.com

    Elanco Animal Health Incorporated (ELAN) Q1 2025 Earnings Call Transcript

    Elanco Animal Health Incorporated (NYSE:ELAN ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Tiffany Kanaga - Head of Investor Relations Jeffrey Simmons - President and ...

    news image

    3 weeks ago · benzinga.com

    Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide

    Elanco Animal Health Incorporated   ELAN reported first-quarter 2025 adjusted earnings per share of 37 cents. That's up 9% year over year.

    news image

    3 weeks ago · zacks.com

    Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics

    While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metr...

    news image

    3 weeks ago · zacks.com

    Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates

    Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.34 per share a ye...

    news image

    3 weeks ago · benzinga.com

    Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

    Elanco Animal Health Incorporated ELAN on Monday announced the sale of certain future tiered royalties and commercial milestones associated with Xdemvy (lotilaner ophthalmic solution) 0.25% for the hu...

    news image

    3 weeks ago · accessnewswire.com

    Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out

    NEW YORK CITY, NY / ACCESS Newswire / May 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the ...

    news image

    1 month ago · accessnewswire.com

    Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire / May 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the ...

    news image

    1 month ago · zacks.com

    Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q1 Earnings Expected to Decline

    Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Add to Watchlist